comparemela.com
  1. Home
  2. Live Updates
  3. Rd Asia Sheng - Breaking News

Rd Asia Sheng News Today : Breaking News, Live Updates & Top Stories | Vimarsana

健康产业奋力开新局 抗疫 利器 显担当_中国经济网——国家经济门户

健康产业奋力开新局 抗疫 利器 显担当_中国经济网——国家经济门户
ce.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ce.cn Daily Mail and Mail on Sunday newspapers.

Glenn guardianRd asia shengAsia shengTechnology innovationSinopharm group chinaHealth sciencePublic health peak forumResearch centerUniversity willy hospitalHealth serviceService innovationResearch medical sciencePublic healthPublic health serviceCo chen qi yuHealth service hall

亚盛医药将携多款 中国智药 首次亮相2021服贸会，彰显全球创新实力-美通社PR-Newswire

中国苏州2021年8月30日 /美通社/ 致力于在肿瘤、乙肝及与衰老相关疾病等治疗领域开发创新药物的领先的生物医药企业 亚盛医药（6855.HK）即将携多款全球领先的原创新药亮相20..

United statesHong kongRd asia shengAsia shengInnovation research forumMayo medical centerB country serviceHealth serviceProfessional forumBeijing shougang parkBooth centralChina chileMedical serviceInter asia shengNew progressDiscussion china genesis

28家创新药企七成业绩增长 研发支出近169亿 _ 东方财富网

【28家创新药企七成业绩增长 研发支出近169亿】半年报披露进入尾声，目前已有28家创新药上市公司交出了年中成绩单，其中七成业绩增长。在创新驱动之下，有21家创新药公司上半年加大了研发投入，浙江医药、复旦张江、丽珠集团等10家研发支出增长超过30%。另外，大多数公司中期业绩报告中透露了核心品种的最新研发进展，部分品种具有较大市场潜力。28家公司合计研发支出近169亿元。（证券时报）

United statesSouth koreaAsia shengRd asia shengKorea pearl groupFudan university zhangjiang beidaFudan university zhangjiang korea pearl groupFudan university zhangjiangFinance genesisProton shengGenesis newNew crownKorea pearlNew progressCountry medicareInnovation independent

亚盛医药公布2021年中期业绩：重要品种临床优势突出，对外合作实现重大突破-美通社PR-Newswire

亚盛医药公布2021年中期业绩：重要品种临床优势突出，对外合作实现重大突破-美通社PR-Newswire
prnasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnasia.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongRd asia shengAsia shengUs pass agency china suzhouMayo medical centerRd centerResearch progressAgency china suzhouUnited states maryland romania augustNew progressChina countryAcademic general assemblyAnnual meetingChina genesisUnited states country

第12项！亚盛医药FDA孤儿药认定再创新高，MDM2-p53抑制剂APG-115获ODD治疗IIB-IV期黑色素瘤-美通社PR-Newswire

第12项！亚盛医药FDA孤儿药认定再创新高，MDM2-p53抑制剂APG-115获ODD治疗IIB-IV期黑色素瘤-美通社PR-Newswire
prnasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnasia.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongRd asia shengAsia shengUs pass agency china suzhouMayo medical centerSociety annual meetinga asia shengAgency china suzhouUnited states maryland romaniaUnited states marketUnited states newSociety annual meetingNew progressCode asia shengCountry scienceMarket marketing
© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.